Bioavailability of beta-adrenoceptor blocking drugs.
作者信息
Johnsson G, Regardh C G
出版信息
Br J Clin Pharmacol. 1976 Dec;3(6):1064-5; author reply 1066. doi: 10.1111/j.1365-2125.1976.tb00361.x.
Abstract
摘要
相似文献
1
Bioavailability of beta-adrenoceptor blocking drugs.β-肾上腺素受体阻断药的生物利用度。
Br J Clin Pharmacol. 1976 Dec;3(6):1064-5; author reply 1066. doi: 10.1111/j.1365-2125.1976.tb00361.x.
2
Comparison of the beta-adrenoceptor blocking activity of oxprenolol, slow release oxprenolol and a combined oxprenolol diuretic preparation.氧烯洛尔、缓释氧烯洛尔及氧烯洛尔利尿剂复方制剂的β-肾上腺素受体阻断活性比较
Br J Clin Pharmacol. 1981 Dec;12(6):869-71. doi: 10.1111/j.1365-2125.1981.tb01323.x.
3
Interaction of calcium antagonists with beta-adrenoceptor blocking agents.钙拮抗剂与β-肾上腺素能受体阻滞剂的相互作用。
Arch Toxicol Suppl. 1986;9:188-96. doi: 10.1007/978-3-642-71248-7_24.
4
Pre-dosing plasma concentrations and beta-adrenoceptor blocking effects during repeated once daily dosing with 160 mg sustained-release propranolol (Inderal LA) and 16/260 oxprenolol Oros to healthy volunteers.对健康志愿者每日一次重复给予160毫克缓释普萘洛尔（心得安长效制剂）和16/260奥昔萘洛尔渗透泵控释片后的给药前血浆浓度及β-肾上腺素受体阻断作用。
Br J Clin Pharmacol. 1985;19 Suppl 2(Suppl 2):197S-201S. doi: 10.1111/j.1365-2125.1985.tb02762.x.
5
Osmotic delivery systems for the beta-adrenoceptor antagonists metoprolol and oxprenolol: design and evaluation of systems for once-daily administration.β-肾上腺素受体拮抗剂美托洛尔和氧烯洛尔的渗透给药系统：每日一次给药系统的设计与评价
Br J Clin Pharmacol. 1985;19 Suppl 2(Suppl 2):69S-76S. doi: 10.1111/j.1365-2125.1985.tb02745.x.
6
Comparison of the duration of action of pindolol and slow release oxprenolol in healthy volunteers.健康志愿者中吲哚洛尔与缓释氧烯洛尔作用持续时间的比较。
Eur J Clin Pharmacol. 1978 Nov 27;14(3):167-9. doi: 10.1007/BF02089955.
7
Once daily dosage beta-blockade: antihypertensive efficacy of slow release oxprenolol as related to renin and age.每日一次剂量的β受体阻滞剂：缓释氧烯洛尔的降压疗效与肾素和年龄的关系
Aust N Z J Med. 1976 Aug;6(3 Suppl):37-43. doi: 10.1111/j.1445-5994.1976.tb03333.x.
8
Oxprenolol in the treatment of anxiety due to environmental stress.氧烯洛尔治疗环境应激所致焦虑症
Am J Psychiatry. 1975 Sep;132(9):965-6. doi: 10.1176/ajp.132.9.965.
9
Controlled evaluation of the beta adrenoceptor blocking drug oxprenolol in anxiety.β-肾上腺素能受体阻断药氧烯洛尔治疗焦虑症的对照评估
Med J Aust. 1976 Jun 12;1(24):909-12.
10
Effects of prolonged administration of oxprenolol on severity of ischaemic arrhythmias, enzyme leakage, infarct size, and intracellular cardiac muscle action potentials.心得平长期给药对缺血性心律失常严重程度、酶漏出、梗死面积及心肌细胞动作电位的影响。
J Cardiovasc Pharmacol. 1984 May-Jun;6(3):369-77. doi: 10.1097/00005344-198405000-00001.
本文引用的文献
1
Plasma propranolol levels in adults with observations in four children.成人血浆普萘洛尔水平及对四名儿童的观察结果
Clin Pharmacol Ther. 1970 Jan-Feb;11(1):112-20. doi: 10.1002/cpt1970111112.
2
The disposition of propranolol. I. Elimination during oral absorption in man.普萘洛尔的处置。I. 人体口服吸收过程中的消除
Pharmacology. 1972;7(3):159-68. doi: 10.1159/000136285.
3
Pharmacokinetics of pindolol in man.吲哚洛尔在人体中的药代动力学。
Eur J Clin Pharmacol. 1974;7(1):17-24. doi: 10.1007/BF00614385.
4
The metabolites of oxprenolol (Trasicor) in man.
Xenobiotica. 1974 Jun;4(6):365-73. doi: 10.3109/00498257409052112.
5
Combined pharmacokinetic and pharmacodynamic studies on alprenolol and 4-hydroxy-alprenolol in man.阿普洛尔和4-羟基阿普洛尔在人体中的药代动力学与药效学联合研究。
Life Sci. 1974 Feb 16;14(4):693-704. doi: 10.1016/0024-3205(74)90452-4.
6
Pharmacokinetic studies of practolol, a beta adrenergic antagonist, in man.β肾上腺素能拮抗剂心得宁在人体的药代动力学研究。
Clin Pharmacol Ther. 1973 Jan-Feb;14(1):26-9. doi: 10.1002/cpt197314126.
7
Pharmacokinetic studies on the selective beta1-receptor antagonist metoprolol in man.人用选择性β1受体拮抗剂美托洛尔的药代动力学研究。
J Pharmacokinet Biopharm. 1974 Aug;2(4):347-64. doi: 10.1007/BF01061407.
8
Prediction of systemic availability from plasma-level data after oral drug administration.
J Pharm Pharmacol. 1973 Mar;25(3):256-7. doi: 10.1111/j.2042-7158.1973.tb10634.x.
9
Studies of the absorption and removal of propranolol in hypertensive patients during therapy.高血压患者治疗期间普萘洛尔吸收与清除情况的研究。
Circulation. 1975 Aug;52(2):313-8. doi: 10.1161/01.cir.52.2.313.
10
Combined pharmacokinetic and pharmacodynammc studies in man of the adrenergic beta1-receptor antagonist metoprolol.肾上腺素能β1受体拮抗剂美托洛尔在人体中的药代动力学和药效学联合研究。
Acta Pharmacol Toxicol (Copenh). 1975;36(Suppl 5):31-44. doi: 10.1111/j.1600-0773.1975.tb03320.x.
Zotero 插件